Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

The Urology Group

Neither a doctor nor a teaching hospital

Research payments

$5,825,898

139 payments

Through program year 2025, The Urology Group is reported as receiving $5,825,898 in research payments, across 139 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $1,485,569 33
2024 Research $1,270,839 32
2023 Research $423,149 8
2022 Research $483,516 11
2021 Research $348,675 12
2020 Research $1,048,798 20
2019 Research $765,352 23

Breakdown

Who paid Research payments · program years 2019–2025
  1. Medivation Inc. $3,033,598 68 payments
  2. Pfizer Inc. $2,587,619 40 payments
  3. Coloplast Corp $93,919 16 payments
  4. Dendreon Pharmaceuticals LLC $74,870 9 payments
  5. Myovant Sciences Inc. $17,231 3 payments
  6. Myriad Genetic Laboratories, Inc. $14,017 1 payment
  7. Boston Scientific Corporation $3,144 1 payment
  8. Urovant Sciences Inc $1,500 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. A Phase 3 Randomized Efficacy and Safety Study of Enzalutamide Plus Leuprolide Enzalutamide Monotherapy and Placebo Plus Leuprolide in Men With Highrisk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy $5,575,009 107 payments
  2. Intibia $93,919 16 payments
  3. ProvONE Study $69,870 8 payments
  4. A Phase 3 Randomized Doubleblind Placebocontrolled Study of Mevrometostat Pf06821497 With Enzalutamide in Metastatic Castrationsensitive Prostate Cancer Mevpro3 $46,208 1 payment
  5. Hero Study Grant $17,231 3 payments
  6. EndoPredict Extended Endocrine Trial (EXET) $14,017 1 payment
  7. ProvONE $5,000 1 payment
  8. Rezum II Pivotal Study $3,144 1 payment
  9. An Exploratory Phase 2a Study Evaluating the Efficacy and Safety of URO-902 in Subjects With Overactive Bladder and Urge Urinary Incontinence $1,500 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record